|March 19, 2013|
|05:55 EDT||ARTC, ARTC, ARTC, ARTC, ARTC, MDT, MDT, MDT, MDT, MDT, MGLN, MGLN, MGLN, MGLN, MGLN, MAKO, MAKO, MAKO, MAKO, MAKO, KYO, KYO, KYO, KYO, KYO, ECL, ECL, ECL, ECL, ECL, COV, COV, COV, COV, COV, CYH, CYH, CYH, CYH, CYH, CFN, CFN, CFN, CFN, CFN, BMTI, BMTI, BMTI, BMTI, BMTI, BAX, BAX, BAX, BAX, BAX, AXGN, AXGN, AXGN, AXGN, AXGN, AUXL, AUXL, AUXL, AUXL, AUXL, OSIR, OSIR, OSIR, OSIR, OSIR||American Academy of Orthopaedic Surgeons to host annual meeting|
AAOS 2013 Annual Meeting is being held in Chicago on March 19-23.
News For ARTC;AUXL;AXGN;BAX;BMTI;CFN;CYH;COV;ECL;KYO;MAKO;MGLN;MDT;OSIR From The Last 14 Days
|November 30, 2015|
|11:06 EDT||OSIR||Osiris recent selloff overdone, says Piper Jaffray|
Piper Jaffray analyst Edward Tenthoff says shares of Osiris Therapeutics have overreacted to the company's revenue restatement. The selloff is overdone and the valuation is attractive at current levels, Tenthoff tells investors in a research note. He views the revenue changes as small compared to total BioSurgery sales. Tenthoff reiterates an Overweight rating on Osiris with a $28 price target.
|November 27, 2015|
|07:29 EDT||BAX||Marcus Evans to hold a conference|
4th Annual Medical Device Safety Monitoring & Reporting Conference is being held in Las Vegas on November 27-28.
|06:59 EDT||MDT||Medtronic volatility flat into Q2 and outlook |
Subscribe for More Information
|November 24, 2015|
|08:31 EDT||MDT||Medtronic remains a top tier performer in Med Device space, says Cowen|
Subscribe for More Information
|November 20, 2015|
|16:41 EDT||OSIR||Osiris to restate certain financial statements|
Osiris Therapeutics previously disclosed in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 that it had undertaken a review of the timing of revenue recognition under contracts with its distributors. As a result of this review, the Company determined to correct the revenue recognition for three contracts, which resulted in a decrease in product revenues of $1.8M in the first quarter of 2015, a decrease in product revenues of $1M in the second quarter of 2015, an increase in product revenues of $0.8M in the third quarter of 2015 and a decrease in product revenues of $1.1M in 2014. Each of these transactions are net of applicable cost of sales. These corrections were reflected in the Third Quarter 2015 Form 10-Q filed with the SEC on November 16, 2015. While the impact of these modifications to the Company's revenue recognition practices for certain distribution contracts is immaterial to its annual financial statements for the year ended December 31, 2014, the impact on the quarterly periods ending March 31, 2015 and June 30, 2015 is material. As a result, the Company will restate its previously issued interim financial statements for first quarter and second quarter of 2015 through the filing of amended Quarterly Reports on Form 10-Q for the quarters ended March 31, 2015 and June 30, 2015. These amended quarterly reports will be filed with the SEC as soon as administratively possible. On November 16 2015, management of the Company, in consultation with the Audit Committee of the Board of Directors and the Company's independent registered public accounting firm, concluded that investors should no longer rely on the Company's previously issued financial statements for the quarterly periods ended March 31, 2015 and June 30, 2015 and on any prior earnings releases or other communications relating to such periods.
|16:35 EDT||CYH||Stocks follow worst week of year with one of best after Fed minutes give clarity|
Stocks ended the week with sharp gains, with the S&P rising over 3%, bouncing back from last week's equally sharp declines. The primary driver of the move appeared to be the Fed minutes, which provided further clarity that December's meeting is firmly on the table for the central bank to make its first rate hike in many years. MACRO NEWS: In the U.S., the minutes from the Fed's last FOMC meeting showed that most participants expect that rate hike conditions will be met by their December meeting. The Fed repeated its constant refrain, though, that the actual decision would depend on the implications for the medium-term outlook from recent economic data... The consumer price index rose 0.2% in October, as expected. When food and energy prices are stripped out, the "core" CPI also rose 0.2%, also matching the consensus forecast. Industrial production slid 0.2% in October, versus expectations for it to have risen 0.1%. Capacity utilization came in as expected at 77.5%. Housing starts fell 11.0% to a 1.06M pace in October, weaker than the expected rate of 1.16M. Building permits, however, rose 4.1% to a 1.15M rate, versus an expected rise of 3.8%. The Empire State index, which measures manufacturing in the N.Y. region, edged up to -10.74 in November, up from last month's -11.4, but below expectations for a -6.5 reading... In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the regions' economy... In Asia, Japan's gross domestic product declined 0.8% in the third quarter, missing expectations for a 0.2% decrease and taking the nation's economy back into recession. Later in the week, the Bank of Japan maintained its current pace of monetary stimulus, as expected. Meanwhile, China's Securities Regulatory Commission has restarted initial public offerings for five companies to list on the Shanghai stock exchange and five in Shenzhen, ending a five-month freeze on IPOs. COMPANY NEWS: Shares of Wal-Mart advanced 3.5% on Tuesday after the world's largest retailer reported better than expected quarterly earnings and gave a fiscal year profit outlook that was higher than expected at the midpoint of the company's range. Another retail giant and fellow Dow member, Home Depot (HD), gained more than 4% that day after its own better than expected quarterly reports, which came on the heels of largely disappointing reports from other major retailers. Target (TGT), however, fell more than 4% on Wednesday after the retailer reported in-line quarterly sales and profits and narrowed the range of its fiscal year earnings view. Among others reporting earnings this week, TJX Companies (TJX) and Keurig Green Mountain (GMCR) rose immediately following their reports, while Kirkland's (KIRK) and Nimble Storage (NMBL) fell right after their own... The biggest U.S. health insurer said Thursday that it is considering pulling out of Obamacare due to losses it has suffered from its participation in the program and cut its profit outlook for this fiscal year, sending its shares and those of its industry peers lower. UnitedHealth (UNH) fell after trimming its fiscal 2015 earnings outlook, citing the Affordable Care Act, and stating that it is "evaluating the viability of the insurance exchange product segment." Aetna (AET), Humana (HUM), Anthem (ANTM) and Cigna (CI) all declined following their rival's announcement, though Aetna and Anthem followed the news up Friday morning by each reaffirming their fiscal 2015 earnings outlooks. Hospital stocks fell as well, with HCA Holdings (HCA), LifePoint (LPNT), Community Health (CYH) and Tenet (THC) all ending the Thursday lower by 6% or more... Square (SQ) rose 45% to close its first day as a publicly-traded company at $13.07 after pricing its initial public offering at $9 per share. Twitter (TWTR), which, like Square, claims Jack Dorsey as its CEO, advanced a bit following Square's public debut as well. Another high-profile tech company also gained in its first day of public trading, as Match Group (MTCH), the owner of dating app Tinder and other online dating services, climbed 22.8% to $14.74 after pricing its IPO at $12 per share... Bloomberg reported that Pfizer (PFE) is nearing an agreement to acquire Allergan (AGN) for $370 to $380 per share, citing people familiar with the matter. CNBC's David Faber then reported that deal talks are in the "final innings" and centered on an all stock transaction whereby Pfizer would offer 11-plus shares per Allergan share. Then, people close to the talks told Financial Times that the U.S. drugmaker is preparing to offer more than $380 per share for Allergan. Amid all these reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers. In other M&A news, Starwood Hotels & Resorts (HOT) found a buyer, but not the one that media reports had been foreshadowing. Starwood and Marriott (MAR) announced a deal under which the companies will combine in a cash and stock transaction valued at $12.2B to create the world's largest hotel company. Canadian Pacific (CP) and Norfolk Southern (NSC) both advanced after Canadian submitted a bid to acquire Norfolk, though the latter immediately criticized the offer as "low-premium." Airgas (ARG) surged about 30% after agreeing to be acquired by France's Air Liquide for $143 per share. Fairchild (FCS) jumped 8.5% after agreeing to be acquired for $20 per share by ON Semiconductor (ON)... Qualcomm (QCOM) dropped sharply after disclosing that Korea's Fair Trade Commission alleged the company does not "properly negotiate" aspects of its licenses and may be violating Korean competition law... SunEdison (SUNE) had another tough week, falling about 43% amid ongoing concerns regarding its liquidity and after quarterly filings revealed that several prominent hedge funds exited or trimmed their stakes in the company... ConAgra (CAG) gained 4% on Wednesday after announcing plans to separate into two independent public companies... Nike (NKE) advanced to close out the week after the footwear and sports apparel giant announced a two-for-one stock split, a $12B stock repurchase program and plans to boost its dividend... Chipotle Mexican Grill (CMG) dropped sharply after the Center for Disease Control announced that three additional states have reported people infected within the E. coli outbreak linked to the company's restaurants. INDEXES: The Dow gained about 3.35% to close at 17,823.81, the S&P 500 rose about 3.27% to close at 2,089.17, and the Nasdaq advanced about 3.58% to close at 5,104.92.
|05:22 EDT||MDT||Stocks with implied volatility movement; MDT UNH|
Stocks with implied volatility movement; Medtronic (MDT) 25, UnitedHealth (UNH) 30 according to iVolatility.
|November 19, 2015|
|16:23 EDT||CYH||On The Fly: Top stock stories for Thursday|
The major averages spent most of the day in a narrow range bouncing around the flatline, seeming content to consolidate the gains from their rally of the last three days. The market internals confirmed the lackluster session, as the number of advancing stocks were generally in line with declining stocks. Oil prices remained under pressure for much of the session, but closed the day little changed, similar to equities. ECONOMIC EVENTS: In the U.S., jobless claims are still near four-decade lows, with 271,000 first-time claims filed in the week ended November 14. The Philly Fed index rose 6.4 points to 1.9 in November, better than the forecast for a -0.5 reading. In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the regions' economy. In Asia, the Bank of Japan maintained its current pace of monetary stimulus, as expected. COMPANY NEWS: The biggest U.S. health insurer said this morning that it is considering pulling out of Obamacare due to losses it has suffered from its participation in the program and cut its profit outlook for this fiscal year, sending its shares and those of its industry peers lower. UnitedHealth (UNH) fell $6.62, or 5.65%, to $110.63 after trimming its fiscal 2015 earnings outlook, citing the Affordable Care Act, and stating that it is "evaluating the viability of the insurance exchange product segment." Meanwhile, Aetna (AET) declined 6.5%, Humana (HUM) dropped 4%, Anthem (ANTM) declined almost 7% and Cigna (CI) slid over 5% following their rival's announcement. Hospital stocks fell as well, with HCA Holdings (HCA), LifePoint (LPNT), Community Health (CYH) and Tenet (THC) all ending the day lower by 6% or more... Last night, Bloomberg reported that Pfizer (PFE) is nearing an agreement to acquire Allergan (AGN) for $370 to $380 per share, citing people familiar with the matter. CNBC's David Faber then reported that deal talks are in the "final innings" and centered on an all stock transaction whereby Pfizer would offer 11-plus shares per Allergan share. Then, people close to the talks told Financial Times that the U.S. drugmaker is preparing to offer more than $380 per share for Allergan. Amid all these reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers. Government intervention concerns appeared to trump the pricing reports, as Allergan closed the day 2.8% lower at $301.73, while Pfizer fell 3% to $32.29 per share... Intel (INTC) rose 3.4% to $34.30 after the chipmaking giant hosted its annual investor meeting, at which it announced an increase to its dividend and guided for "mid-single digits" percentage revenue growth in fiscal 2016. MAJOR MOVERS: Among the notable gainers was Keurig Green Mountain (GMCR), which surged $7.38, or 18.22%, to $47.88 after it reported better than expected quarterly earnings and guided for fiscal 2016. Also higher was Square (SQ), which rose $4.07, or 45%, to close its first day as a publicly-traded company at $13.07 after pricing its initial public offering at $9 per share. Twitter (TWTR), which, like Square, claims Jack Dorsey as its CEO, gained 1.6% to $26.32 following Square's public debut. Another high-profile tech company also gained in its first day of public trading, as Match Group (MTCH), the owner of dating app Tinder and other online dating services, climbed 22.8% to $14.74 after pricing its IPO at $12 per share. Among the noteworthy losers was Kirkland's (KIRK), which fell nearly 33% to $13.60 after the company reported downbeat quarterly earnings and provided lower than expected guidance. Also lower were shares of AMAG Pharmaceuticals (AMAG), which lost 9.84% to $26.20 after it received a complete response letter from the FDA for its proposed treatment to reduce the risk of preterm birth in at-risk patients. INDEXES: The Dow fell 4.41, or 0.02%, to 17,732.75, the Nasdaq slid 1.56, or 0.03%, to 5,073.64, and the S&P 500 declined 2.34, or 0.11%, to 2,081.24.
|November 18, 2015|
|14:34 EDT||ECL||Ecolab management to meet with William Blair|
Meeting to be held in Baltimore on November 24 hosted by William, Blair.
|November 17, 2015|
|10:00 EDT||OSIR||On The Fly: Analyst Downgrade Summary|
Today's noteworthy downgrades include: Airgas (ARG) downgraded on valuation at KeyBanc... BHP Billiton (BHP) downgraded to Neutral from Buy at Clarksons Platou... Chesapeake (CHK) downgraded to Neutral from Buy at Sterne Agee CRT... ChipMOS (IMOS) downgraded to Equal Weight from Overweight at Morgan Stanley... Clovis (CLVS) downgraded to Neutral from Conviction Buy at Goldman... Cooper Companies (COO) downgraded to Market Perform from Outperform at Wells Fargo... Five Below (FIVE) downgraded to Neutral from Buy at Sterne Agee CRT... Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities... Hess Corp. (HES) downgraded to Perform from Outperform at Oppenheimer... J Sainsbury (JSAIY) downgraded to Neutral from Buy at Citi... Kindred Biosciences (KIN) downgraded to Market Perform from Outperform at BMO Capital... Leju (LEJU) downgraded to Neutral from Buy at BofA/Merrill... Lombard Medical (EVAR) downgraded to Equal Weight from Overweight at Barclays... Osiris (OSIR) downgraded to Sell from Hold at Brean Capital... Polaris Industries (PII) downgraded on anemic ORV growth at Wedbush... SQM (SQM) downgraded to Hold from Buy at HSBC... Southwestern Energy (SWN) downgraded to Underperform from Neutral at Sterne Agee CRT... Starwood (HOT) downgraded to Outperform from Buy at CLSA... Urban Outfitters (URBN) downgraded to Hold from Buy at Cantor... WM Morrison (MRWSY) downgraded to Sell from Neutral at Citi... adidas (ADDDY) downgraded to Sector Perform from Outperform at RBC Capital... athenahealth (ATHN) downgraded to Underweight from Equal Weight at Barclays.
|09:15 EDT||OSIR||On The Fly: Pre-market Movers |
UP AFTER EARNINGS: Nuance (NUAN), up 9.1%... Cheetah Mobile (CMCM), up 7.7%... Eros International (EROS), up 12.8%... Home Depot (HD), up 3.1%...Wal-Mart (WMT), up 2.2%. ALSO HIGHER: Ocera Therapeutics (OCRX), up 14.8% after announcing Phase 1 study results for the company's oral formulation of OCR-002... Fitbit (FIT), up 2.4% after being upgraded to Buy from Neutral at BofA/Merrill. DOWN AFTER EARNINGS: Dicks Sporting Goods (DKS), down 15.4%... Urban Outfitters (URBN), down 12.8%. ALSO LOWER: Osiris Therapeutics (OSIR), up 25.5% after being downgraded to Sell from Hold at Brean Capital... Angie's List (ANGI), down 8.7% after board unanimously determines not to pursue IAC (IACI) proposal... Clovis Oncology (CLVS), down 4.1% after receiving downgrades from Goldman and WallachBeth... Chesapeake Energy (CHK), down 2.5% after being downgraded to Neutral from Buy at Sterne Agee CRT... Cooper Companies (COO), down 2% after being downgraded to Market Perform from Outperform at Wells Fargo.
|09:14 EDT||MDT||Medtronic announces FDA approval, launch of MyCareLink Smart Monitor|
Subscribe for More Information
|06:08 EDT||OSIR||Osiris downgraded to Sell from Hold at Brean Capital|
Brean Capital analyst Jason Wittes downgraded Osiris Therapeutics to Sell with an $8 price target. The stock closed yesterday down 33c to $13.98. The company's quarterly filing shows evidence of "aggressive accounting, particularly in regard to revenue recognition," Wittes tells investors in a research note. There are three restatements from distributor relationships, two in addition to the initial one management noted on the earnings conference call, the analyst contends.
|November 16, 2015|
|07:22 EDT||OSIR||Brean Capital to hold a summit|
Subscribe for More Information
|06:11 EDT||BAX||Baxter resumed with a Neutral from Overweight at Piper Jaffray|
Piper Jaffray analyst Brooks West downgraded Baxter (BAX) to Neutral after resuming coverage of the name. The company, post the spin of Baxalta (BXLT), "has a number of moving pieces that need to be addressed," West tells investors in a research note. He lowered his price target for shares to $39 from $90.